2 Ways to Save on ONFI
FREE 14-day trial for all patients

Activate Your ONFI Savings Right Now!

    For eligible commercial patients*:
  • Start your FREE 14-Day Trial
  • Save on your prescription copay

*Medicaid patients and other federal health care program beneficiaries, patients who are self-pay, and patients who do not have insurance coverage for ONFI are not eligible. Eligible commercial patients must be at least 2 years old to participate. See complete Terms and Conditions below.

Terms and Conditions for the ONFI 14-Day Free Trial and
Copay Assistance Programs

General Terms and Conditions: Only commercially insured patients age 2 and older whose insurance policy provides coverage for ONFI® (clobazam) and who are not reimbursed for the entire cost of the prescription are eligible for the 14-day free trial voucher or copay assistance (the "Offers"). Patients are not eligible for the Offers if they are self-pay or if the prescription is eligible to be reimbursed, in whole or in part, by any state or federal health care programs, including but not limited to Medicare or Medicaid, Medigap, VA, DOD, or TRICARE. In addition, patients may not use the Offers if they are Medicare-eligible and enrolled in an employer-sponsored health plan or prescription drug benefit program for retirees.
Offers are valid only for use with a valid prescription for ONFI at the time the prescription is filled by the pharmacist and dispensed to the patient. Offers apply only to prescriptions filled before the programs expire. The free trial and copay prescriptions shall not be submitted for reimbursement to any public third-party payer, including Medicaid or Medicare or any other similar federal or state healthcare program; in addition, the free trial prescription shall not be submitted to any private third-party payer. Patients are responsible for complying with any obligations or requirements imposed by their insurance plans.
The Offers are not transferable. The selling, purchasing, trading, or counterfeiting of the Offers is prohibited by law. The Offers have no cash value and may not be used in combination with any other discount, coupon, rebate, free trial, or similar offer for the specified prescription.
Lundbeck reserves the right to rescind, revoke, or amend the Offers without notice. Offers are intended to comply with all applicable laws and regulations, including, without limitation, the federal Anti-Kickback Statute, its implementing regulations, and related guidance interpreting the federal Anti-Kickback Statute. Offers are not health insurance. Offers are valid only in the USA where allowed by law. There is no future purchase requirement associated with the Offers. Patient questions and requests to discontinue participation in the programs can be directed to 1-855-809-5818 (8:00 am-8:00 pm ET, Monday through Friday).
14-Day Free Trial Terms and Conditions: To participate in this program, eligible commercially insured patients age 2 and older must present the 14-day free trial voucher to the pharmacist along with their valid prescription. By participating in the 14-Day Free Trial, the patient acknowledges and agrees that he/she is eligible to participate and that he/she understands and agrees to comply with the General and 14-Day Free Trial Terms and Conditions.
Copay Assistance Terms and Conditions: Eligible patients must present their activated card to the pharmacist along with their valid Onfi prescription to participate in this program. Use of the Copay Assistance program will require patients to pay a minimum of $10 out-of-pocket expense for each 30-day prescription. To be eligible, patients must have a copay that exceeds $10 for each 30-day prescription. A maximum benefit of $600 may apply for each 30-day prescription. If the patient's total out-of-pocket pharmacy bill exceeds the cap established by Lundbeck, the patient will be responsible for the additional balance. Patients should talk to their pharmacist to determine the maximum amount that they could pay based on their prescribed dosage and insurance benefits. By participating in the Copay Assistance program, the patient acknowledges and agrees that he/she is eligible to participate and that he/she understands and agrees to comply with the General and Copay Assistance Terms and Conditions.
To the Pharmacist:

  • Submit transaction to McKesson Corporation using BIN #610524.
  • For the copay card, if primary coverage exists, input card information as secondary coverage and transmit using the COB segment of the NCPDP transaction. Applicable discounts will be displayed in the transaction response.
  • Acceptance of this card and your submission of claims are subject to the LoyaltyScript® program. Terms and Conditions posted at www.mckesson.com/mprstnc.
  • For questions regarding setup, claim transmission, patient eligibility, or other issues, call the LoyaltyScript® program at 1-855-809-5818 (8:00 am-8:00 pm ET, Monday through Friday).

What is ONFI®?

ONFI [(clobazam) CIV] is a prescription medicine used along with other medicines to treat seizures associated with Lennox-Gastaut syndrome in people 2 years of age or older.



See Medication Guide and full Prescribing Information for complete information.

ONFI is a benzodiazepine medicine. Taking benzodiazepines with opioid medicines, alcohol, or other central nervous system (CNS) depressants (including street drugs) can cause severe drowsiness, breathing problems (respiratory depression), coma, and death.

Get emergency help right away if any of the following happens:

  • Shallowed or slowed breathing
  • Breathing stops (which may lead to the heart stopping)
  • Excessive sleepiness (sedation)

Do not drive or operate heavy machinery until you know how taking ONFI with opioids affects you.

There is a risk of abuse, misuse, and addiction with benzodiazepines, including ONFI, which can lead to overdose and serious side effects including coma and death.

  • Serious side effects may also include delirium, paranoia, suicidal thoughts or actions, seizures, and difficulty breathing.
  • You can develop an addiction even if you take ONFI as prescribed by your healthcare provider.
  • Take ONFI exactly as your healthcare provider prescribed.
  • Do not share your ONFI with other people AND keep ONFI in a safe place and away from children.

ONFI can cause physical dependence and withdrawal reactions. Stopping or decreasing ONFI dosage suddenly after continued use may cause serious withdrawal reactions, which can be life-threatening, including unusual movements, responses, or expressions, seizures, sudden and severe mental or nervous system changes, depression, seeing or hearing things that others do not, an extreme increase in activity or talking, losing touch with reality, and suicidal thoughts or actions.


Do not take ONFI if you have a known allergy to ONFI or its ingredients.

ONFI can make you sleepy or dizzy and slow your thinking and motor skills. Do not drive, operate heavy machinery, or do other dangerous activities until you know how ONFI affects you. Do not drink alcohol or take other drugs that may make you sleepy or dizzy while taking ONFI without first talking to your healthcare provider. ONFI may make your sleepiness or dizziness much worse.

Serious skin reactions have been seen when ONFI is taken with other medicines and may require stopping its use. A serious skin reaction can happen at any time during your treatment with ONFI. Call your healthcare provider immediately if you have skin blisters, rash, sores in the mouth, hives, or any other allergic reaction.

Like other seizure medicines, ONFI may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Call your healthcare provider right away if you have any symptoms of depression, especially sudden changes in mood, behaviors, thoughts, or feelings, and especially if they are new, worse, or worry you. Stopping a seizure medicine suddenly in a patient who has epilepsy can cause seizures that will not stop.

Before you take ONFI, tell your healthcare provider about all your medical conditions, including if you:

  • Have liver or kidney problems
  • Have lung problems (respiratory disease)
  • Have or have had depression, mood problems, or suicidal thoughts or behavior
  • Are pregnant or plan to become pregnant
    • Taking ONFI late in pregnancy may cause your baby to have symptoms of sedation (breathing problems, sluggishness, low muscle tone) and/or withdrawal symptoms (jitteriness, irritability, restlessness, shaking, excessive crying, feeding problems).
    • Tell your healthcare provider right away If you become pregnant or think you are pregnant while taking ONFI
    • If you become pregnant while taking ONFI, talk to your healthcare provider about registering with the North American Antiepileptic Drug Registry. For more information, go to http://www.aedpregnancyregistry.org or call 1-888-233-2334.
  • If you are breastfeeding or plan to breastfeed. ONFI can pass into breast milk.
    • Breastfeeding during treatment with ONFI may cause your baby to have sleepiness, feeding problems, and decreased weight gain. Talk to your healthcare provider about the best way to feed your baby if you take ONFI.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Taking ONFI with certain other medicines can cause side effects or affect how well they work. ONFI may make your birth control medicine less effective. Talk to your healthcare provider about the best birth control method to use. Do not start or stop ONFI or other medicines without talking to your healthcare provider.

ONFI oral suspension should be kept in its original bottle in an upright position and used within 90 days of first opening the bottle. After 90 days, safely throw away any unused ONFI oral suspension.

The most common side effects of ONFI include: sleepiness; drooling; constipation; cough; pain with urination; fever; acting aggressive; being angry or violent; difficulty sleeping; slurred speech; tiredness; and problems with breathing.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

For more information, please see the full Prescribing Information, including Boxed Warning, Medication Guide and Instructions for Use, or go to ONFI.com.